Phase 2 trial finds bezisterim shows safety and symptom gains in long COVID, with strongest benefits for severe fatigue, PEM, and cognitive issues.
|Videos|July 22, 2021
Paving a Path Forward to Overcome Stigma
Author(s)Shahla Modir, MD
A recent All Points North Lodge survey found 37% of Americans are comfortable discussing mental health, but 44.7% have never tried counseling. What is preventing them from seeking care?
Advertisement
Despite the difficult past 2 years, negative views of mental health persist. Shahla Modir, MD, discusses the results of the
To see more from this survey, check out
Dr Modir is the Chief Medical Officer at All Points North Lodge and the Chief Psychiatrist at Avalon Malibu, Summit Malibu.
Advertisement
Related to this article
There is a question older than medicine, and perhaps older than philosophy, that psychiatry has largely avoided: What makes us human?
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Psych Consult: TSH Testing in New-Onset Depression. An Endocrinologist’s Guidance for Psychiatrists
2
ADHD Medications for Managing Menopausal Brain Fog: Improvements in Subjective Executive Function
3
New Phase 2 Data on Bezisterim for the Treatment of Long COVID
4
What Do Patient-Level Studies Tell Us About Antidepressants and Suicide Risk?
5